Cargando…
Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority
The COVID-19 pandemic was immediately marked by strong clinical research activity. The French national competent authority presents the data on request for authorization during the first 2 years of COVID-19 pandemic to inform discussions on future clinical research issues. Applications for authoriza...
Autores principales: | Vignot, Stéphane, Dhanani, Alban, Sainte-Marie, Isabelle, de Ligniville Lajavardi, Laure, Even, Gwennaelle, Echemann, Muriel, Hulin, Nina, Ménoret, Claire, Maison, Patrick, Ratignier-Carbonneil, Christelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421368/ https://www.ncbi.nlm.nih.gov/pubmed/36046816 http://dx.doi.org/10.3389/fphar.2022.972660 |
Ejemplares similares
-
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
por: Vignot, Stéphane, et al.
Publicado: (2021) -
Clinical Trial Authorisation: A Final Look Back to Better Appraise the New European Regulation
por: Vignot, Stéphane, et al.
Publicado: (2023) -
The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study
por: Benhabib, Amine, et al.
Publicado: (2020) -
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
por: Maison, Patrick, et al.
Publicado: (2022) -
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience
por: Belgodère, Laëtitia, et al.
Publicado: (2023)